We performed a pharmacokinetic analysis of the blood thiamin profile after oral administration of thiamin tetrahydrofurfuryl disulfide (TTFD) to healthy adults. To distinguish between thiamin derived from TTFD ingestion and that from previous dietary intake, the baseline thiamin level was subtracted from the apparent blood vitamin levels measured after administration. Following administration of 100 mg of TTFD, the peak blood thiamin level was almost 10 times the baseline level and the blood thiamin profile could be simulated by a two -compartment model to obtain reasonable pharmacokinetic parameters. When the blood thiamin profile for a 10-mg dose of TTFD was estimated using scaled-down pharmacokinetic parameters derived at the 100-mg dose level, a reasonable fit for the raw data obtained at 10-mg dose was obtained. Therefore, the parameters derived from the data at a dose of 100 mg appeared to be reliable. Since even 180 mg of TTFD is completely absorbed and the absorption ratio is independent of the dose, it can be concluded that gastrointestinal absorption of TTFD is good within the dose range. Key Words pharmacokinetics, simulation, area under the curve, thiamin, thiamin tetrahydrofurfuryl disulfide (TTFD), blood thiamin level, humans
Summary
We performed a pharmacokinetic analysis of the blood thiamin profile after oral administration of thiamin tetrahydrofurfuryl disulfide (TTFD) to healthy adults. To distinguish between thiamin derived from TTFD ingestion and that from previous dietary intake, the baseline thiamin level was subtracted from the apparent blood vitamin levels measured after administration. Following administration of 100 mg of TTFD, the peak blood thiamin level was almost 10 times the baseline level and the blood thiamin profile could be simulated by a two -compartment model to obtain reasonable pharmacokinetic parameters. When the blood thiamin profile for a 10-mg dose of TTFD was estimated using scaled-down pharmacokinetic parameters derived at the 100-mg dose level, a reasonable fit for the raw data obtained at 10-mg dose was obtained. Therefore, the parameters derived from the data at a dose of 100 mg appeared to be reliable. Since even 180 mg of TTFD is completely absorbed and the absorption ratio is independent of the dose, it can be concluded that gastrointestinal absorption of TTFD is good within the dose range. Key Words pharmacokinetics, simulation, area under the curve, thiamin, thiamin tetrahydrofurfuryl disulfide (TTFD), blood thiamin level, humans
The water-soluble thiamins are absorbed by a saturable, specialized absorption process, and their intestinal absorption is dose-dependent and very poor (1) . Consequently, little pharmacokinetic evaluation of thiamin has been performed.
Thiamin tetrahydrofurfuryl disulfide (TTFD) is a thiamin derivative which is readily absorbed from the gastrointestinal tract. Oral administration of TTFD causes a significant increase in the blood thiamin level which is equivalent to that achieved by the intravenous administration of water-soluble thiamins (2) . During the absorption of TTFD from the gastrointestinal tract, its S-S bond is broken to N . KITAMORI and Y. ITOKAWA generate thiamin (3). Therefore, a pharmacokinetic evaluation of the thiamin level after the administration of TTFD should be possible . We have already reported on several studies in which TTFD was administered to healthy male adults (4) (5) (6) . In the present study, we used the results of these previous investigations for pharmaco kinetic analysis.
Another reason for the lack of pharmacokinetic investigations on vitamins may be the difficulty of discriminating between the vitamin derived from the administration of a vitamin preparation and that derived from previous dietary intake. In general, the best method for evaluating the profile of vitamin in blood or plasma is considered to be by using a labeled compound. However, the pharmaco kinetic evaluation of blood vitamin level should be based on the intact form of the vitamin alone, while the total radioactivity level may include the metabolites of a vitamin. Thus, even when a labeled compound is used , it is still difficult to evaluate the pharmacokinetics of a vitamin unless its intact form is analyzed separately .
As a simple substitute for the use of labeled compounds , we have proposed that the baseline level of a vitamin can be subtracted from the apparent blood level observed after the administration of an unlabled vitamin preparation (7) . METHODS 1. Source of the blood thiamin data. Our previous human studies involved the single administration of tablets containing 10 mg of TTFD (equivalent to 6 .65 mg of thiamin) (4), the repeated administration of multivitamin tablets containing 10mg of TTFD for 7 days (4), the single administration of tablets containing 100 mg of TTFD (5), and the single administration of 100mg of TTFD powder (6) . Informed consent was obtained from each subject at these studies . The mean values (n=6) in these studies were used for the simulation. The experimental methods were described in the previous papers.
2. Pharmacokinetic analysis of blood thiamin data . Simulation of the blood thiamin profile was performed using the program designed by Yamaoka and Tanigawa (8) . The parameters of the model equation were selected to obtain the best fit to the data using the least-squares method .
We found that a two-compartment model with first-order absorption could describe the blood thiamin profile with reasonable parameters . When simulation of the blood thiamin profile following oral administration was performed using a model with a lag time before absorption, the results fitted the observed data better .
The two-compartment model with first-order absorption that we used is shown in Fig. 1 .
The equation describing the model was as follows:
Cp=Ae-ƒ¿(t-t0)+Be-ƒÀ(t-t0)-(A+B)e-Ka(t-t0) , 
and (4) 
(8)
For calculation of Vc, the value of F (the absorption ratio) was assumed to be "1."
RESULTS AND DISCUSSION
To analyze the blood thiamin profiles caused by administration of TTFD, we used the change in the blood thiamin level from the baseline (7). This method can vol. 39, No. 5, 1993 Table 2 . Pharmacokinetic parameters of thiamin after a 100-mg dose of TTFD. Table 3 . Mean blood thiamin levels following single or repeated administration of 10-mg dose of TTFD (n=6) (4). Table 4 . Pharmacokinetic parameters of thiamin after a 10-mg dose of TTFD. dose study; Ba data for last day during the 1-week repeated dose study; estimated curves are the same).
As shown in Fig. 3 , the blood thiamin profile estimated using 1/10 values for the constants A and B obtained at a dose of 100mg were in good agreement with the data of the 10-mg studies. This result suggests that the pharmacokinetic parameters obtained from the 100-mg studies were more reliable than those from 10-mg studies.
The fact that the pharmacokinetic parameters obtained from the 100-mg studies on the tablet and powder forms of TTFD were almost identical, while those obtained from the four 10-mg studies were different, also suggests that the former set of parameters were more reliable. The rate of the oral absorption generally decreases with an increase in the dose. The fact that the parameters of the 10-mg dose were equal to the ones of 100-mg dose means that the parameters are not dose-dependent and therefore the absorption ratio is equivalent between two doses. Aso et al. (3) administered 30mg of TTFD labeled with 35S at the VB 1 moiety together with 150mg of unlabeled compound to humans, and found that it was completely absorbed as thiamin. Since even 180 mg of TTFD was completely absorbed, 10 or 100mg of TTFD would be completely absorbed from the gastroin testinal tract, Therefore, it was felt to be appropriate to assume that the absorption ratio (F) was unity when the simulation was carried out.
